TLSI: Szela Mary T reports tax withholding on shares
By AlphaYouPublished Form 4
Szela Mary T
Reporting filer
Szela Mary T reports tax withholding on shares, not an open-market purchase or sale, in TriSalus Life Sciences, Inc.. Form 4 filed Oct 7, 2026 lists 1 entry.
- Disclosed
- Oct 7, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Szela Mary T | 2026-10-05 | F | Tax/exercise withholding | 2693 | 4.38 | 1,074,990 | 2 days | Filed terms
|
Common Stock
- Owner
- Szela Mary T
- Date
- 2026-10-05
- Code
- F
- Action
- Tax/exercise withholding
- Quantity
- 2693
- Price
- 4.38
- Following holdings
- 1,074,990
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-05
- transaction Form Type: 4
- transaction Code: F
- equity Swap Involved: 0
- transaction Shares: 2693
- id: F1
- transaction Price Per Share: 4.38
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 1074990
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Szela Mary T: CEO and President, Director.
- F1: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units previously granted.
Original sources
Prepared automatically from public filing data. Report a correction.